pelabresib,ruxolitinib
constellation Pharmaceuticals,novartis,morphosys,incyte
['#myelof', 'manifest trial', 'manifest,(-manifest-2),(-manifest2),(-manifest 2),(-manifest-i),(-manifesti),(-manifest i)', 'morphosys']
new analyses from the manifest trial presented at #ash22 suggest that our investigational bet inhibitor may have the potential to provide symptom relief and disease modification for people with #myelofibrosis. learn more: 
Global commercial-stage biopharmaceutical company driven by our mission: More life for people with cancer.